Carbapenem-resistant disseminated melioidosis with pulmonary, cardiac and cutaneous involvement: a case report
DOI:
https://doi.org/10.53843/bms.v11i15.1150Keywords:
Melioidosis, Lung Diseases, Endocarditis, Burkholderia pseudomallei, Microbial Drug ResistanceAbstract
Introduction: Melioidosis is an infectious disease caused by Burkholderia pseudomallei, a Gram-negative bacterium found in soil and water in tropical regions of the world, especially in Southeast Asia and Northern Australia. Report: This case report describes a patient with disseminated melioidosis caused by Burkholderia pseudomallei, with pulmonary, cardiac and cutaneous manifestations. The infection showed resistance to carbapenems, making therapeutic management difficult. The diagnosis was challenging due to the nonspecific clinical presentation and the rarity of the disease in non-endemic regions. Laboratory confirmation allowed the institution of targeted antimicrobial treatment, with favorable clinical evolution and significant improvement of the condition. Discussion: Melioidosis is a serious infectious disease, often underdiagnosed outside of endemic areas such as Southeast Asia and Northern Australia. In Brazil, it has already been identified in several states, especially Ceará, where cases have increased and generally evolve to a severe form. Its nonspecific symptoms make diagnosis difficult, as they can mimic other infections. The causative bacterium, Burkholderia pseudomallei, shows increasing resistance to antibiotics, such as carbapenems, which complicates treatment. The disease can affect multiple organs and, although rare, can cause endocarditis. This scenario reinforces the need for greater epidemiological surveillance, early diagnosis, identification of antimicrobial resistance and training of health professionals, even in regions outside the traditionally affected areas. Conclusion: This case highlights the importance of clinical suspicion of melioidosis in patients with multiple infectious foci, especially in tropical areas, and reinforces the need for agile diagnostic protocols and knowledge about emerging bacterial resistance.
References
1. Rolim DB, et al. Melioidose: guia prático. Fortaleza: Universidade de Fortaleza; 2021. ISBN: 978-65-992087-2-0.
2. Nagoba BS, et al. Multi-systemic melioidosis: cases. World Journal of Clinical Cases. 2024;12(28):6151–4. doi:10.12998/wjcc.v12.i28.6151.
3. Tripathi S, et al. Primary cutaneous melioidosis - a rare case needing intensive care unit admission. Southern African Journal of Critical Care. 2024;40(2):e1362. doi:10.7196/SAJCC.2024.v40i2.1362.
4. Carrillo-Bayona JA, et al. Imaging manifestations of pulmonary melioidosis: a case series. Radiologia (English Edition). 2022;64(5):484–8. doi:10.1016/j.rxeng.2022.09.002.
5. Zhang Y, et al. Combatting melioidosis with chemical synthetic lethality. Proceedings of the National Academy of Sciences. 2024;121(46):e2406771121. doi:10.1073/pnas.2406771121.
6. Ceará. Secretaria de Saúde do Estado. Nota Técnica nº 01/2021 - Vigilância em Saúde da melioidose no Estado do Ceará. Fortaleza: SESA; 2021. Available from: https://www.saude.ce.gov.br.
7. Dadwal P, et al. Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes. PLOS Neglected Tropical Diseases. 2024 Jul 17. doi:10.1371/journal.pntd.0012317.
8. Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, Limmathurotsakul D. Melioidosis. Nature Reviews Disease Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107. PMID: 29388572; PMCID: PMC6456913.
9. Whitmore A, et al. An account of a glanders-like disease occurring in Rangoon. Journal of Hygiene, London. 1913;13:1–34. doi:10.1017/S0022172400005234.
10. Velusamy R, et al. Melioidosis and the heart: a systematic review. Tropical Medicine and Infectious Disease. 2020;5:121. doi:10.3390/tropicalmed5030121.
11. Sivabalan P, et al. Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure. Access Microbiology. 2024;6:000619.v4.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Lorena Alves Trajano, Fernando Moreira Batista Aguiar, Filadélfia Passos Rodrigues Martins, Kaio Rangel Freitas Guimarães

This work is licensed under a Creative Commons Attribution 4.0 International License.
User licenses define how readers and the general public can use the article without needing other permissions. The Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders can use to share original works of authorship and other material subjects to copyright and certain other rights specified in the public license available at https:// creativecommons.org/licenses/by/4.0/deed.pt_BR. Using the 4.0 International Public License, Brazilian Medical Students (BMS) grants the public permission to use published material under specified terms and conditions agreed to by the journal. By exercising the licensed rights, authors accept and agree to abide by the terms and conditions of the Creative Commons Attribution 4.0 International Public License.